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Abstract 
BACKGROUND: We have assessed the role of stress on compliance of patients with diabetes 
mellitus (DM) and hypertension (HTN) with taking prescribed medications and following dietary 
and exercise regimens. 
METHODS: A total of 9544 individuals more than 19 years of age were selected from three 
counties in central Iran. The presence of DM and HTN were asked from participants. We 
defined treatment adherence (compliance) based on agreement of individual’s self-report 
behavior with recommendations from a physician. 
RESULTS: Awareness about DM and HTN was 82.6% and 49.9%, respectively. Multivariate 
analysis showed that odds ratio (OR) of high to low stress level was lower than one for both 
“usage of medication” and “following exercise regimen” in diabetics even after adjustment for 
either “age and sex” or “age, sex and education”. In hypertensive patients, OR of high to low 
stress level was lower than one for “usage of medication” even after adjustment for either “age 
and sex” or “age, sex and education” and also lower than one for “following exercise regimen” 
only as crude index. 
CONCLUSION: Cases with higher stress level had lower compliance for accepting either 
medication or exercise as a treatment option for their DM or HTN. 
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Introduction 
The new era of disease control is obviously about 
chronic diseases that need long term management 
programs to be followed by either health systems or 
patients. In this dilemma, several factors play 
important roles to ensure effective and efficient 
service provision for the Management of Chronic 
Diseases (MCD); among them, patients’ adherence 
to treatment and compliance with medications are 
considered important factors.1,2  
Adherence was defined as “the extent to which the 
patient follows medical instructions”3 or more 
extensively as “the extent to which a person’s behavior 
such as taking medication, following a diet, and/or 
following lifestyle changes, corresponds with agreed 
recommendations from a health care provider”.4,5 
Compliance can be defined as “taking medications as 
prescribed”,6 and has deep impact on MCD.7,8 
Previous studies have reported the rate of good 
compliance with medication in patients with 
hypertension (HTN) to be between 9.6%-74%,9-12 and 
compliance with modifications in cardiovascular risk 
factors was between 39.3%-62.8%13 and in patients 
with diabetes mellitus (DM) between 38%-79%.7  
Many factors (including psychological factors) 
are proposed to affect compliance in chronic 
diseases such as anxiety, depression, age, race and 
perceived social support.14-16 The role of depression 
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has been studied extensively17-21 but despite the 
proposed role of stress and anxiety in the 
development and management of DM,17,22-25 little is 
known about the role of stress in etiology of HTN 
and its impact on patient's compliance with 
treatment. The role of anxiety and stress on factors 
affecting MCD especially following treatment 
regimens is still an issue. 
The aim of this study was to assess the role of 
stress on the compliance of patients with DM and 
HTN with treatment programs such as taking 
prescribed medications and following dietary and 
exercise regimens. 
Materials and Methods 
Data of this study was part of the ‘‘Isfahan Healthy 
Heart Program’’ (IHHP), a community-based 
program designed to prevent and control 
cardiovascular diseases in Iran. The main goal of 
IHHP was promotion of healthy nutrition and 
increasing physical activity and conducting stress 
management and tobacco control activities. The 
IHHP design was described in detail elsewhere.26,27 
Multistage cluster random sampling was used to 
stratify the study population based on living area 
(urban or rural) according to the national census in the 
last survey of the IHHP in 2007. In total, 9544 men 
and women over 19 years old from three counties in 
central Iran (Isfahan, Najafabad and Arak), were 
selected for this study. To achieve adequate sample 
size, those who declined to participate in the study 
were replaced by their neighbors. 
The total number of participants for this study 
was determined according to their sex, age, and area 
of residence compared with the entire population. 
Approximately 5%-10% of households within these 
clusters were randomly selected for inclusion. 
According to the 2006 national census, the 
population was 1986542 in Isfahan and 282430 in 
Najafabad, a county neighboring Isfahan. Arak, with 
a population of 615702 is located 375 km northwest 
of Isfahan.27,28 
Individuals who were pregnant, mental retard or 
physically disabled (all according to medical history by 
cases or their families) were excluded from the study. 
After clarifying the study protocol and study 
process, written informed consent was obtained. 
Data on demographic and socioeconomic 
characteristics and lifestyle behaviors were recorded 
by a trained interviewer at baseline. We also 
collected some data about the presence of DM, 
HTN, type of medication, patient's compliance and 
lifestyle habits. The study protocol was reviewed 
and approved by the Ethics Committee of Isfahan 
University of Medical Sciences, Iran. 
Demographic factors included age, sex, and 
education level (classified as 0–5 years, 6–12 years, 
and > 12 years). 
Psychological distress was assessed by 12-item 
General Health Questionnaire (GHQ-12), a self-
administered well established screening tool.29 This 
questionnaire is a consistent and reliable instrument 
for using in general population studies.30 The 
questionnaire consists of 12 items with four-point 
scale (less than usual, no more than usual, fairly more 
than usual, or much more than usual). The 0-0-1-1 
method was used to score the GHQ-12 
questionnaires in this study. Using this method, a 
participant could score between 0 and 12 points; with 
a score of 4 or more identified as high stress level. 
After at least 12 hours fasting, all individuals 
were referred to the nearest health center to their 
home for taking a blood sample to measure their 
fasting blood sugar (Pars Azmon, Tehran, Iran). 
Before blood sampling from the veins of the anti-
cubital region, blood pressure was measured for all 
participants in the sitting position twice with an 
interval of 5-10 minutes. Prevalence of DM and 
HTN, patients' awareness of their diseases and the 
difference between their awareness of their disease 
and the actual prevalence according to physical 
examination and laboratory data were evaluated in 
this study. For calculating the exact prevalence of 
DM and HTN, we used either self-reports of the 
disease related medications or laboratory 
examination results since cases under treatment for 
these conditions (medical or non-medical) may have 
normal values of fasting blood glucose (FBS) or 
blood pressure. On the other hand, there were cases 
with abnormal FBS or blood pressure that were not 
aware of their diseases. 
In this study, we defined treatment compliance 
based on whether patients took their medications 
properly and followed dietary and exercise 
recommendations or not. Self-reported responses to 
three separate questions were based on yes/no scale. 
“Yes” answers were considered good compliance. 
The SPSS software for Windows (version 15.0, 
SPSS Inc., Chicago, IL, USA) was used for 
analyzing data. Quantitative variables were 
expressed as mean ± standard deviation (SD). To 
compare continuous variables between subjects 
with high and low stress level, Student’s t-test was 
used. Categorical variables were compared between 
these two groups using chi-square. Logistic 
regression analysis (Enter method) was used to 
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determine the effect of independent variables such 
as DM and HTN, usage of medications for these 
two diseases according to the physician’s advice 
(medical compliance), and non-medical advices such 
as diet and exercise (non-medical compliance) on 
stress level of the cases in the treatment of the DM 
and HTN. Age, gender and education level were 
considered for adjustment. Analyses of medication, 
diet or exercise were done in cases that were aware 
of their diseases. A P-value < 0.05 was considered 
statistically significant. 
Results 
Mean age of the participants was 38.7 ± 15.5 years 
and 4772 (50%) were male. Subjects with higher 
stress level were significantly older (39.5 ± 16.2 vs. 
38.4 ± 15.2, P = 0.001), were more likely female 
(57.9% vs. 45.9%, P < 0.001) and had lower 
education level. The prevalence of diabetes was 404 
(6.5%) and 238 (7.8%) in low and high stress 
individuals (P = 0.113), respectively. Also, the 
prevalence of hypertension was 1055 (17.1%) in low 
stress and 619 (19.3%) in high stress individuals  
(P = 0.08) (Table 1). 
 
Table 1. Characteristics of all individual according to 
stress level* 
Indicator Low stress High stress P  n = 6289 n = 3260 
Age (mean ± SD) 38.41 ± 15.19 39.51 ± 16.24 0.001 
Sex (Male) [n(%)] 3402 (54.1) 1375 (42.1) < 0.001 
Education (Year)   < 0.001 
0-5  2677 (42.6) 1619 (49.7) 
6-12 2699 (43.0) 1278 (39.2) 
> 12 901 (14.4) 363 (11.1) 
Diabetes [n(%)] 404 (6.5) 238 (7.8) 0.113 
Hypertension [n(%)] 1055 (17.1) 619 (19.3) 0.008 
*Data are expressed as mean ± standard deviation (SD) for 
continuous variables and number (percentage) of participants 
for categorical variables 
 
As table 2 shows, only 325 cases among 404 
(82.6%) with low stress and 205 cases among 238 
(86.1%) with high stress were aware of their DM. 
According to table 3, 510 (48.3%) individuals with 
low stress and 326 (52.7%) with high stress were 
aware of their HTN. 
Patients with either HTN or DM in the high 
stress group had a significantly lower percentage of 
medication usage (P = 0.018 and P < 0.001, 
respectively) and were less likely to follow 
recommended exercise regimen (P = 0.039 and  
P = 0.032, respectively) Following dietary restrictions 
was not significantly different between cases with low 
and high stress levels (Tables 2 and 3). 
 
Table 2. Treatment regimens of individuals who were 
aware of their diabetes 
Treatment 
[n(%)] 
Low stress High stress P  
n = 325 n = 205 
Medication 307 (94.6) 177 (86.5) 0.018 
Diet  222 (68.3) 144 (70.1) 0.665 
Exercise  73 (22.5) 36 (17.5) 0.039 
 
Multivariate analysis showed that the odds ratio 
(OR) of high stress to low stress level was lower 
than one for both usages of medication and 
following exercise regimen in diabetics as crude 
index and even after adjustment for either age and 
sex or age, sex and education (Table 4). In 
hypertensive patients, OR of high stress to low 
stress level was lower than one for usage of 
medication as crude index and even after 
adjustment for either age and sex or age, sex and 
education and was also lower than one for following 
exercise regimen only as crude index (Table 4). It 
means lower compliance of cases with high stress 
level in comparison with patients with low stress 
level to accepting either medication or exercise as a 
treatment option for their DM or HTN. 
 
Table 3. Treatment regimens of individuals who were 
aware of their hypertension 
Treatment 
 
Low stress 
[n(%)] 
High stress 
[n(%)] 
P  
n = 510 n = 326 
Medication  478 (93.6) 279 (85.7) < 0.001 
Diet  317 (62.2) 213 (65.3) 0.088 
Exercise  130 (25.6) 61 (18.8) 0.032 
 
Discussion 
This study was a part of IHHP that was designed to 
assess the impact of community-based programs in 
prevention and control of cardiovascular diseases 
and their risk factors.31,32 Our findings showed that 
higher levels of stress in patients with HTN or DM 
had independent impact on compliance with 
medication and exercise, but not for dietary 
recommendations; the level of stress regardless of 
age, sex and education level had an independent 
effect on compliance, specially taking medication in 
both hypertensive and diabetic patients.  
There are many sophisticated models of 
interaction between stress and chronic diseases such 
as HTN and DM, mostly emphasizing a 
biopsychosocial model. In this model, stress has 
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Table 4. Crude and adjusted odds ratio (95% confidence interval) of treatment regimens of diabetes and hypertension 
with stress level 
Variable Unadjusted Adjusted (age and sex) Adjusted (age, sex and education) 
Prevalence of diabetes 1.14 (0.97, 1.35) 1.05 (0.88, 1.25) 1.04 (0.88, 1.24) 
Treatment regimens of diabetes    
Medication 0.41 (0.29, 0.87) 0.41 (0.29, 0.88) 0.41 (0.29, 0.90) 
Diet 1.09 (0.74, 1.59) 0.96 (0.65, 1.42) 0.91 (0.61, 1.36) 
Exercise 0.70 (0.64, 0.76) 0.76 (0.70, 0.83) 0.77 (0.70, 0.84) 
Prevalence of hypertension 1.16 (1.04, 1.30) 1.09 (0.96, 1.23) 1.09 (0.96, 1.23) 
Treatment regimens of hypertension    
Medication 0.41 (0.35, 0.67) 0.45 (0.37, 0.74) 0.45 (0.37, 0.88) 
Diet 1.10 (0.71, 1.73) 1.12 (0.75, 1.94) 1.13 (0.65, 1.94) 
Exercise 0.67 (0.47, 0.97) 0.75 (0.52, 1.09) 0.76 (0.52, 1.11) 
 
biological effects such as changes in endocrine 
stress modulating systems including hypothalamus-
pituitary-adrenal (HPA) axis. Stress has also impacts 
on illness behavior, on modifying risk factors and 
therapeutic recommendation. All of them would 
result in initiation and continuation of chronic 
diseases through a multi-factorial model.33,34 There 
are several reports claiming stress and other 
psychological factors as etiologies of DM.22,35 In our 
study, there was no difference in stress level 
between subjects with or without HTN/DM and 
based on our findings, we were unable to show the 
role of stress in the pathogenesis of HTN or DM. 
However, it may be involved in the management of 
these disorders. This contradiction could be 
attributed to the design of our study that only 
evaluated patients' current stress level and did not 
consider the chronic stress state.  
Interestingly, less than half of the subjects were 
aware of their high blood pressure; while in the case 
of DM about 82.6% were aware of their condition. 
Comparing with the previous IHHP survey that 
reported awareness rates of HTN and DM to be 
40.3% and 54.6%, respectively,36 it seems that as the 
project proceeded, there was a significant increase 
in awareness for DM. On the other hand, awareness 
of HTN showed no significant change from 
previous phase of IHHP. This may be related to 
differences in subjective and cultural believes about 
DM and HTN as IHHP targets both conditions 
with similar goals,31,36 and may denote need for 
establishment of new strategies regarding increasing 
awareness of HTN. In assessment of compliance to 
medications, diet and exercise, we were limited to 
include only subjects who were aware of their 
disease, so we did not have access to data about 
possible medication/diet/exercise adherence of 
non-aware subjects in relation to stress level. In 
another IHHP report in 2007, investigators found 
negative impact of high stress level on diet but not 
on exercise and physical activity. That study 
enrolled all target population from the community 
regardless of having HTN and or DM.37 We found 
no relationship between stress and diet in patients 
with HTN and or DM, which may indicate that 
stress shows its effect on life style factors of chronic 
diseases in at risk but not diseased population. This 
may have implications in prevention strategies and 
interventions to implement programs with target to 
manage stress levels in at risk populations. 
While there are no established etiologic 
pathways,16 it seems that stress and other 
psychological attributes play important role in 
compliance of patients with HTN and DM.19-21,38-40 
So, they can be considered as targets for HTN and 
DM management and control programs.41 
Addressing depression and anxiety in compliance 
improving programs would provide better chance 
to deal with management of chronic medical 
conditions such as DM and HTN. This effect 
would possibly act via several hypothetical pathways 
such as modification of monoamines implicated in 
stress and depression as well as other medical and 
psychological conditions that encounter disease and 
health, providing more adequate treatment regimens 
to subjects. These assumptions need to be studied 
deeply in further studies. 
A limitation to this study is lack of information 
about long term stress levels in subjects and lack of 
differentiating stress trait and state. If such data was 
gathered, it might have contributed to more 
comprehensive understanding of the relationship 
between stress and HTN/DM. It is suggested to 
use inventories in further studies to overcome this 
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issue. Another limitation is that the assessment of 
compliance about medication was based on self-
report by cases. 
Conclusion 
Management of depression and anxiety symptoms 
generally experienced as stress by the patient could 
be an efficient method in management of DM and 
HTN and possibly other chronic diseases. 
Addressing stress in clinical and community 
management of these chronic medical conditions 
would improve health status of patients via several 
routs such as improving compliance to 
medications, exercise and diet. 
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